eribulin

Poland

Drugs containing this active substance

  • ERIBULIN EVER PHARMA

    The medicine is intended for adults with advanced breast cancer or metastatic breast cancer (after other therapies have ceased to be effective). It is also used in the treatment of advanced liposarcoma or metastatic liposarcoma, when other treatment methods have proven ineffective.

    Form: solution for injection

    Active substance Dosage
    eribulin 0.44 mg/ml

    ATC: L01XX41

    Manufacturer: EVER Pharma Jena GmbH Oncomed manufacturing a.s.